JP2025532665A5 - - Google Patents

Info

Publication number
JP2025532665A5
JP2025532665A5 JP2025517108A JP2025517108A JP2025532665A5 JP 2025532665 A5 JP2025532665 A5 JP 2025532665A5 JP 2025517108 A JP2025517108 A JP 2025517108A JP 2025517108 A JP2025517108 A JP 2025517108A JP 2025532665 A5 JP2025532665 A5 JP 2025532665A5
Authority
JP
Japan
Prior art keywords
antigen
cancer
antibody
amino acid
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025517108A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025532665A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/119761 external-priority patent/WO2024061223A1/zh
Publication of JP2025532665A publication Critical patent/JP2025532665A/ja
Publication of JP2025532665A5 publication Critical patent/JP2025532665A5/ja
Pending legal-status Critical Current

Links

JP2025517108A 2022-09-20 2023-09-19 腫瘍への抵抗における抗体およびその使用 Pending JP2025532665A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202211142594 2022-09-20
CN202211142594.0 2022-09-20
PCT/CN2023/119761 WO2024061223A1 (zh) 2022-09-20 2023-09-19 抗体及其在抗肿瘤中的应用

Publications (2)

Publication Number Publication Date
JP2025532665A JP2025532665A (ja) 2025-10-01
JP2025532665A5 true JP2025532665A5 (cg-RX-API-DMAC7.html) 2026-02-09

Family

ID=90453915

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025517108A Pending JP2025532665A (ja) 2022-09-20 2023-09-19 腫瘍への抵抗における抗体およびその使用

Country Status (5)

Country Link
EP (1) EP4592315A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025532665A (cg-RX-API-DMAC7.html)
KR (1) KR20250075621A (cg-RX-API-DMAC7.html)
CN (1) CN119894933A (cg-RX-API-DMAC7.html)
WO (1) WO2024061223A1 (cg-RX-API-DMAC7.html)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0590058B1 (en) 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
JP2006500921A (ja) 2002-07-30 2006-01-12 ブリストル−マイヤーズ スクイブ カンパニー ヒト4−1bbに対するヒト化抗体
EP3698807A1 (en) * 2005-01-21 2020-08-26 Genentech, Inc. Fixed dosing of her antibodies
RU2727165C2 (ru) 2015-05-04 2020-07-21 ПИЕРИС ФАРМАСЬЮТИКАЛС ГмбХ Слитый полипептид с противораковой активностью
WO2018090950A1 (zh) * 2016-11-18 2018-05-24 北京韩美药品有限公司 抗pd‐1/抗her2天然抗体结构样异源二聚体形式双特异抗体及其制备
AU2020357944A1 (en) 2019-09-30 2022-03-31 Adimab, Llc CH1 domain variants engineered for preferential light chain pairing and multispecific antibodies comprising the same
CN113004415B (zh) * 2019-12-19 2022-09-30 合肥瀚科迈博生物技术有限公司 靶向her2和4-1bb的双特异性抗体及其应用
CN114195894B (zh) * 2020-09-17 2025-02-25 普米斯生物技术(珠海)有限公司 一种靶向4-1bb的抗体及其应用
CN114195900B (zh) * 2020-09-17 2024-02-23 普米斯生物技术(珠海)有限公司 一种抗4-1bb/pd-l1双特异性抗体及其用途
WO2023020537A1 (zh) * 2021-08-18 2023-02-23 普米斯生物技术(珠海)有限公司 一种双特异性抗体及其用途

Similar Documents

Publication Publication Date Title
JP7502549B2 (ja) 抗体-薬物コンジュゲートの薬物部位を認識する蛋白質
CN103987730B (zh) 特异性结合c-met的sema域中表位的抗体
JP6586648B2 (ja) 抗プログルカゴン抗体
CN108659131B (zh) 一种抗ceacam-5的单域抗体及其应用
JP2023527937A5 (cg-RX-API-DMAC7.html)
RU2012126098A (ru) Антикластериновые антитела и антигенсвязывающие фрагменты и их использование для уменьшения объема новообразований
US11820831B2 (en) Antibody binding to carbonic anhydrase and use thereof
US10975160B2 (en) Antibody binding to carbonic anhydrase and use thereof
WO2023219147A1 (ja) Ccr8検出用新規抗ccr8抗体
CN110139874A (zh) 抗ceacam6抗体及其使用方法
JP2018535649A5 (cg-RX-API-DMAC7.html)
JP2024542944A5 (cg-RX-API-DMAC7.html)
JP2024020436A (ja) Her2標的化剤
CN105452297A (zh) mAb 2抗-Met抗体
JP2025513930A5 (cg-RX-API-DMAC7.html)
CN118791613A (zh) 抗msln纳米抗体及其制备方法与用途
JP2024533993A5 (cg-RX-API-DMAC7.html)
KR20140073215A (ko) 세포 분리용 조성물, 키트 및 이를 이용한 세포 분리 방법
CN120535623B (zh) Cdh17结合分子及其用途
CN110579610A (zh) 用于检测t细胞活化的v域免疫抑制因子的试剂盒
US8883972B2 (en) High specificity monoclonal antibody against a protein or a polypeptide having oxidative modification
CN118255886A (zh) 抗msln纳米抗体及其制备方法与用途
CN120923624A (zh) 可结合人cd137单克隆抗体或其功能性片段及其应用
CN120665192A (zh) 一种靶向cdh17的驼类纳米抗体、结合分子及其用途
RU2021137558A (ru) Новое антитело, специфичное к CTHRC1, и его применение